MEN1309
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEN1309, covering 2021-09-28 to 2021-09-28. Get the full timeline:
Most recent: Clinical Trial Update: MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study [Phase 1]